Tolerability of ORM-12741 and effects on episodic memory in patients with Alzheimer's disease

INTRODUCTION: ORM-12741 is a novel selective antagonist of alpha-2C adrenoceptors. This trial evaluated the safety and efficacy of ORM-12741 in patients with Alzheimer's disease (AD). METHODS: A randomized, double-blind, placebo-controlled, exploratory phase 2a trial was conducted in 100 subjec...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Alzheimers Dement (N Y)
Glavni autori: Rinne, Juha O., Wesnes, Keith, Cummings, Jeffrey L., Hakulinen, Pasi, Hallikainen, Merja, Hänninen, Jutta, Murphy, Michael, Riordan, Henry, Scheinin, Mika, Soininen, Hilkka, Rouru, Juha
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2016
Teme:
Featured Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5651366/
https://ncbi.nlm.nih.gov/pubmed/29067315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2016.11.004
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items